ARMP
Price
$2.03
Change
+$0.03 (+1.50%)
Updated
Dec 18, 04:38 PM (EDT)
85 days until earnings call
PRME
Price
$2.65
Change
-$0.27 (-9.28%)
Updated
Dec 18, 04:59 PM (EDT)
77 days until earnings call
Ad is loading...

ARMP vs PRME

Header iconARMP vs PRME Comparison
Open Charts ARMP vs PRMEBanner chart's image
Armata Pharmaceuticals
Price$2.03
Change+$0.03 (+1.50%)
Volume$498
CapitalizationN/A
Prime Medicine
Price$2.65
Change-$0.27 (-9.28%)
Volume$5.27K
CapitalizationN/A
ARMP vs PRME Comparison Chart
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARMP vs. PRME commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a StrongBuy and PRME is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ARMP: $2.00 vs. PRME: $2.91)
Brand notoriety: ARMP and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 355% vs. PRME: 95%
Market capitalization -- ARMP: $70.56M vs. PRME: $346.26M
ARMP [@Biotechnology] is valued at $70.56M. PRME’s [@Biotechnology] market capitalization is $346.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARMP and PRME are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 3 TA indicator(s) are bullish.

  • PRME’s TA Score: 3 bullish, 6 bearish.

Price Growth

ARMP (@Biotechnology) experienced а -9.50% price change this week, while PRME (@Biotechnology) price change was -9.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

ARMP is expected to report earnings on Mar 13, 2025.

PRME is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($346M) has a higher market cap than ARMP($72.4M). ARMP YTD gains are higher at: -38.272 vs. PRME (-67.156).
ARMPPRMEARMP / PRME
Capitalization72.4M346M21%
EBITDAN/AN/A-
Gain YTD-38.272-67.15657%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash37.9MN/A-
Total Debt168MN/A-
FUNDAMENTALS RATINGS
ARMP vs PRME: Fundamental Ratings
ARMP
PRME
OUTLOOK RATING
1..100
556
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8390
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRME's Valuation (71) in the null industry is in the same range as ARMP (80) in the Biotechnology industry. This means that PRME’s stock grew similarly to ARMP’s over the last 12 months.

PRME's Profit vs Risk Rating (100) in the null industry is in the same range as ARMP (100) in the Biotechnology industry. This means that PRME’s stock grew similarly to ARMP’s over the last 12 months.

PRME's SMR Rating (100) in the null industry is in the same range as ARMP (100) in the Biotechnology industry. This means that PRME’s stock grew similarly to ARMP’s over the last 12 months.

ARMP's Price Growth Rating (83) in the Biotechnology industry is in the same range as PRME (90) in the null industry. This means that ARMP’s stock grew similarly to PRME’s over the last 12 months.

ARMP's P/E Growth Rating (93) in the Biotechnology industry is in the same range as PRME (100) in the null industry. This means that ARMP’s stock grew similarly to PRME’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRME
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ARMP and

Correlation & Price change

A.I.dvisor tells us that ARMP and FGHQF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARMP and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
-0.50%
FGHQF - ARMP
25%
Poorly correlated
N/A
QSI - ARMP
23%
Poorly correlated
-8.67%
ADPT - ARMP
22%
Poorly correlated
-3.83%
ALT - ARMP
22%
Poorly correlated
-6.67%
PRME - ARMP
22%
Poorly correlated
-3.00%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-3.00%
CRSP - PRME
64%
Loosely correlated
+0.88%
BEAM - PRME
62%
Loosely correlated
-1.21%
NTLA - PRME
60%
Loosely correlated
-1.87%
RXRX - PRME
56%
Loosely correlated
-4.30%
ABCL - PRME
54%
Loosely correlated
-2.45%
More